Zacks Investment Research on MSN
Abbott (ABT) is a top-ranked value stock: Should you buy?
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks ...
6h
Assessing Abbott Laboratories (ABT) Valuation After Q4 2025 Earnings Miss And Softer 2026 Guidance
Abbott Laboratories (ABT) is back in focus after its fourth quarter 2025 earnings, where revenue of US$11.46b missed Wall ...
Healthcare product and device company Abbott Laboratories (NYSE:ABT) missed Wall Street’s revenue expectations in Q4 CY2025 ...
StockStory.org on MSN
Why Abbott Laboratories (ABT) shares are sliding today
What Happened? Shares of healthcare product and device company Abbott Laboratories (NYSE:ABT) fell 8.3% in the afternoon ...
Abbott Laboratories reported Q4 2025 sales of $11.46 billion, an increase of 4.4% from the previous year but falling short of analyst projections by approximately 3%. The adjusted EPS was $1.50, ...
Abbott Laboratories fell on its latest earnings report, but I view this as a buying opportunity. Read the latest analysis on ...
Abbott Labs stock drops on sales miss and weak guidance for 2026, analyst cuts price target but maintains rating.
Abbott shares sank 8% as Q4 revenue of $11.5B missed the $11.8B target, with nutrition sales dropping 8.9% on price ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback